胶原蛋白和明胶的全球市场-2022-2029

市场动态

全球胶原蛋白和明胶市场慢性病的兴起、人口老龄化的迅速扩大以及再生医学资金的增加是推动全球对再生医学胶原蛋白和明胶需求的重要因素。因为它正在增长。此外，由于预期寿命延长和肉类产量增加，亚太和南美等新兴经济体为这些地区提供了重要机会，这主要导致慢性病。

慢性病的流行将推动市场增长

胶原蛋白和明胶存在于人体中，尤其是皮肤和骨骼中。一定年龄后，体内胶原蛋白的正常发育会下降。缺乏胶原蛋白会导致慢性疾病，如骨质疏鬆症、骨骼和关节疼痛、慢性伤口、心血管疾病和其他神经退行性疾□□病。由于这些慢性疾病会导致器官和组织的破坏，因此需要开发恢復组织的治疗方法。例如，根据美国疾病控制和预防中心 (CDC) 的数据，心血管疾病是全球第一大死因，2020 年估计每年有 697,000 人死亡。

严格的规定以及胶原蛋白和明胶替代品的存在

来自牛和猪的胶原蛋白具有传播疾病的风险，这是对胶原蛋白和明胶需求的主要限制。此外，欧盟（EU）对这些补充剂进行了严格的限制，这也是对目标市场的阻碍。此外，在预测期内，越来越多地使用生物材料替代胶原蛋白和明胶也对胶原蛋白和明胶市场的增长构成重大挑战。

COVID-19 影响分析

COVID-19 正在对全球各个市场产生负面影响。突然的封锁和航空公司禁令扰乱了供应炼和製造单位的流动。这些因素对市场份额产生了负面影响。根据最近的研究，胶原蛋白在对抗 COVID-19 等疾病方面发挥着关键作用。这些结果有利于药物和疫苗的开发，目前发挥着重要作用。这些属性将推动未来的市场增长。

行业分析

全球胶原蛋白和明胶市场根据各种行业因素（包括波特五力、监管分析、供应链分析和定价分析）对市场进行了深入分析。

内容

第一章研究方法与范围

• 调查方法
• 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

• 按产品类型划分的市场细分
• 按应用划分的市场细分
• 按来源划分的市场细分
• 按地区划分的市场细分

第 4 章市场动态

• 市场影响因子
  • 驱动程序
    • 用于研发的政府和私人资金
    • 老龄化社会的快速进步
    • 慢性病增加
  • 约束因素
    • 替代生物材料的可用性
  • 影响分析

第五章行业分析

• 波特五力分析
• 供应链分析
• 价值链分析
• PEST 分析
• 定价分析
• 监管分析
• 保险报销分析
• 未满足的需求
• 专利趋势

第 6 章 COVID-19 分析

• COVID-19 的市场分析
  • COVID-19 之前的市场情景
  • COVID-19 的当前市场情景
  • COVID-19 后或未来情景
• COVID-19 期间的价格动态
• 供需范围
• 大流行期间与市场相关的政府举措
• 製造商的战略举措
• 总结

第 7 章按产品类型

• □
• 明胶

第 8 章按应用程序

• 药品
• 食物和饮料
• 化妆品
• 营养保健品
• 医疗保健
• 其他

第九章来源

• 牛
• 羊
• 猪
• 鸡
• 海鲜
• 其他

第 10 章按地区划分

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 意大利
  • 西班牙
  • 其他欧洲
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 其他亚太地区
• 中东和非洲

第 11 章竞争格局

• 竞争场景
• 市场情况/份额分析
• 併购分析

第 12 章公司简介

• Collagen Solutions Plc
  • 公司概况
  • 产品组合和描述
  • 主要亮点
  • 财务摘要
• Darling Ingredients Inc.
• Ewald-Gelatine GmbH
• GELITA AG
• GELNEX
• Holista Colltech Limited
• LAPI GROUP SpA
• Rousselot
• Tessenderlo Group
• Trobas Gelatine BV.（List Not Exhaustive）

第 13 章胶原蛋白和明胶全球市场-DataM

Market Overview

Collagen & Gelatin Market size was valued US$ 5010.6 million in 2021 and is estimated to reach US$ 7019.6 million by 2029, growing at a CAGR of 5.0% during the forecast period (2022-2029).

Collagen peptide is a cold-soluble and easily digested type of collagen. It is the essential building block that makes up about 30% of the human body's protein. Collagen peptide contains higher concentrations of glycine, hydroxyproline, and proline. Likewise, gelatin is primarily composed of two components, such as proline and amino acid glycine. It is derived from animal bones, lungs, and fibrous tissues. Gelatin is essential for proper hair, skin, and nail development, weight control, and optimal immune function.

Market Dynamics

The global collagen & gelatin market is growing due to the increasing prevalence of chronic diseases, rapid growth in ageing populations, and increased funding for regenerative medicines are essential factors driving the global demand for collagen & gelatin for regenerative medication. Moreover, emerging economies, such as Asia-Pacific and South America, offer significant opportunities in these regions, mainly due to increased life expectancy resulting in chronic diseases and increased meat production.

Rising prevalence of chronic diseases drives the growth of the market

Collagen & gelatin are present in the human body, particularly in the skin and bones. The normal development of collagen in the body declines after a certain age. Lack of collagen causes chronic diseases such as osteoporosis, bone and joint pain, chronic wounds, cardiovascular diseases, and other neurodegenerative disorders. These chronic diseases result in organ and tissue destruction, leading to the creation of treatments that can restore tissues. For instance, according to the centres for disease control and prevention (CDC), in United States, cardiovascular diseases are the leading cause of death globally, accounting for 697,000 people deaths per year in 2020.

Strict regulations and the presence of substitutes for collagen & gelatin

Collagen derived from bovine and porcine sources carries the risk of disease transmission, which is the primary constraint on the demand for collagen & gelatin. Another aspect that hinders the target market is the tight limitations on these supplements by the European Union. Moreover, the increasing use of biomaterials, which alternate to collagen & gelatin, is a significant challenge for the growth of the collagen & gelatin market in the forecast period.

COVID-19 Impact Analysis

COVID-19 has had a negative impact on different markets around the world. Due to sudden locking restrictions and a ban on airlines, there is a split in the movement of supply chain and manufacturing units. These factors negatively disrupted market shares. Collagen has played a significant role in the war against diseases such as COVID-19 in recent studies. These results are beneficial in developing a drug or vaccine that is a critical part of the current situation. These attributes would boost the growth of the market in the future.

Industry Analysis

The global collagen & gelatin market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis.

Segment Analysis

The collagen segment is expected to hold the largest market share in global collagen & gelatin market

The collagen segment dominating growth is primarily driven because increasing end-use applications such as growing usage in the food & beverage industry and an upsurge in demand from the cosmetics industry. Although, partial hydrolysis of collagen contributes to the formation of gelatin. The gelatin segment dominates the market due to its high use in the food & beverage, cosmetics, and medical industries. Also, the growing number of chronic disease patients and the increasing number of ageing shares of the entire population in the developing countries are further estimated to lead the growth of the segment worldwide during the forecast period.

Geographical Analysis

North America region holds the largest market share in the global collagen & gelatin market

North America was held a dominant position in the global collagen & gelatin market in 2021. In North America, the US is expected to represent considerable growth during the forecast period. In the US, the collagen & gelatin market is projected to grow exponentially due to the rising prevalence of chronic diseases in the region. Moreover, South America is expected to represent significant growth in terms of value during the forecast period. Availability of government and private funding for R&D is expected to propel market growth across the region. Collagen & Gelatin market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the region's ageing population's development, especially in India and China. Moreover, increasing research on collagen & gelatin-based products is the primary factor creating a lucrative opportunity for the growth of the Asia Pacific collagen & gelatin market in the forecast years.

Competitive Landscape

The collagen & gelatin market is highly competitive, owing to big market players in the industry. The key collagen & gelatin players which are contributing to the growth of the global market include Rousselot, Collagen Solutions Plc, Darling Ingredients Inc., Ewald-Gelatine GmbH, GELITA AG, GELNEX, Holista Colltech Limited, LAPI GROUP SpA, Tessenderlo Group, Trobas Gelatine B.V. among others. The major players are adopting new product development and expansion strategies for global growth in the collagen & gelatin market.

Key Companies to Watch

Rousselot:

Overview: Rousselot is one the global leader in collagen-based solutions* for the food, health & nutrition, (bio)medical, and pharmaceutical sectors. The company offers Peptan, Peptan IIm, ProTake, Rousselot world-class gelatins, SiMoGel, StabiCaps, Synergy Systems, and X-Pure. It primarily serves nutrition and health, biomedical, food, pharmaceuticals, and technical market companies. Rousselot was founded in France in 1891 by Edouard Rousselot.

Product Portfolio:

X-Pure gelatins offer premium-grade solutions, with tunable functionalities and low endotoxins ≤ 10 EU/g, and are one of the most favorable biomaterials for tissue or stem cell bioengineering. X-Pure products are customizable and include X-Pure Gelatin, X-Pure GelMA, and X-Pure GelDAT.

The global collagen & gelatin market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Product Type
• 3.2. Market Snippet by Application
• 3.3. Market Snippet by Source
• 3.4. Market Snippet by Region

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Government and private funding for R&D
    • 4.1.1.2. Rapid growth in ageing population
    • 4.1.1.3. Rising prevalence of chronic diseases
  • 4.1.2. Restraint
    • 4.1.2.1. Availability of alternate biomaterials
  • 4.1.3. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Value Chain Analysis
• 5.4. PEST Analysis
• 5.5. Pricing Analysis
• 5.6. Regulatory Analysis
• 5.7. Reimbursement Analysis
• 5.8. Unmet Needs
• 5.9. Patent Trends

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
  • 7.1.2. Market Attractiveness Index, By Product Type Segment
• 7.2. Peptide
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Gelatin

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.1.2. Market Attractiveness Index, By Application Segment
• 8.2. Pharmaceutical
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Food and beverage
• 8.4. Cosmetic
• 8.5. Nutraceutical
• 8.6. Healthcare
• 8.7. Others

9. By Source

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 9.1.2. Market Attractiveness Index, By Application Segment
• 9.2. Bovine
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Sheep
• 9.4. Porcine
• 9.5. Chicken
• 9.6. Marine
• 9.7. Others

10. By Region

• 10.1. Introduction
• 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
• 10.3. Market Attractiveness Index, By Region
• 10.4. North America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. US.
    • 10.4.6.2. Canada
    • 10.4.6.3. Mexico
• 10.5. Europe
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. Germany
    • 10.5.6.2. U.K.
    • 10.5.6.3. France
    • 10.5.6.4. Italy
    • 10.5.6.5. Spain
    • 10.5.6.6. Rest of Europe
• 10.6. South America
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.6.6.1. Brazil
    • 10.6.6.2. Argentina
    • 10.6.6.3. Rest of South America
• 10.7. Asia Pacific
  • 10.7.1. Introduction
  • 10.7.2. Key Region-Specific Dynamics
  • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.7.6.1. China
    • 10.7.6.2. India
    • 10.7.6.3. Japan
    • 10.7.6.4. Australia
    • 10.7.6.5. Rest of Asia Pacific
• 10.8. Middle East and Africa
  • 10.8.1. Introduction
  • 10.8.2. Key Region-Specific Dynamics
  • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Collagen Solutions Plc
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Darling Ingredients Inc.
• 12.3. Ewald-Gelatine GmbH
• 12.4. GELITA AG
• 12.5. GELNEX
• 12.6. Holista Colltech Limited
• 12.7. LAPI GROUP SpA
• 12.8. Rousselot
• 12.9. Tessenderlo Group
• 12.10. Trobas Gelatine BV. (List Not Exhaustive)

13. Global Collagen & Gelatin Market - DataM

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us